Specific Lactobacillus species differentially activate Toll-like receptors and downstream signals in dendritic cells

Expert Review of Vaccines

Volumn 7, Issue 8, 2008, Pages 1155-1164

  Mohamadzadeh, Mansour ^a   Klaenhammer, Todd R ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Adjuvant; Dendritic cell; Lactobacillus; MAP kinase; Toll like receptor

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LACTOBACILLUS; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; TH1 CELL;

CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-12; LACTOBACILLUS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TOLL-LIKE RECEPTORS;

EID: 53849096759     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.8.1155     Document Type: Article

References (49)

1. Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold AE, Molin G. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 85, 88-94 (1998).
2. Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J. Nutr. 130, 403S-409S (2000).
3. Guarner F, Schaafsma GJ. Probiotics. Int. J. Food Microbiol. 39, 237-238 (1998).
4. Johansson ML, Nobaek S, Berggren A et al. Molin G. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. Int. J. Food Microbiol. 42, 29-38 (1998).
5. Klaenhammer TR. Probiotic bacteria: today and tomorrow. J. Nutr. 130, 415S-416S (2000).
6. Kullen MJ, Klaenhammer TR. Genetic modification of intestinal lactobacilli and bifidobacteria. Curr. Issues Mol. Biol. 2, 41-50 (2000).
7. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29, 342-346 (1999).
8. Holt PG, Jones CA. The development of the immune system during pregnancy and early life. Allergy 55, 688-697 (2000).
9. Holt PG, Rudin A, Macaubas C et al. Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children. J. Allergy Clin. Immunol. 105, 1117-1122 (2000).
10. Holt PG, Stumbles PA. Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J. Allergy Clin. Immunol. 105, 421-429 (2000).
11. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159, 1739-1745 (1997).
12. Mohamadzadeh M, Olson S, Kalina WV et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl Acad. Sci. USA 102, 2880-2885 (2005).
13. Steinman RM. Dendritic cells: understanding immunogenicity. Eur. J. Immunol. 37(Suppl. 1) S53-S60 (2007).
14. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 449, 419-426 (2007).
15. Kelsall BL, Strober W. Peyer's patch dendritic cells and the induction of mucosal immune responses. Res. Immunol. 148, 490-498 (1997).
16. Kelsall BL, Strober W. Dendritic cells of the gastrointestinal tract. Springer Semin. Immunopathol. 18, 409-420 (1997).
17. Mohamadzadeh M, Berard F, Essert G et al. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 194, 1013-1020 (2001).
18. Mohamadzadeh M, Ariizumi K, Sugamura K, Bergstresser PR, Takashima A. Expression of the common cytokine receptor γ chain by murine dendritic cells including epidermal Langerhans cells. Eur. J. Immunol. 26, 156-160 (1996).
19. Mohamadzadeh M, McGuire MJ, Smith DJ, Gaspari AA, Bergstresser PR, Takashima A. Functional roles for granzymes in murine epidermal γ(δ) T-cell-mediated killing of tumor targets. J. Invest. Dermatol. 107, 738-742 (1996).
20. Mohamadzadeh M, Poltorak AN, Bergstressor PR, Beutler B, Takashima A. Dendritic cells produce macrophage inflammatory protein-1 γ, a new member of the CC chemokine family. J. Immunol. 156, 3102-3106 (1996).
21. Reid G, Sanders ME, Gaskins HR et al. New scientific paradigms for probiotics and prebiotics. J. Clin. Gastroenterol. 37, 105-118 (2003).
22. Grangette C, Muller-Alouf H, Goudercourt D, Geoffroy MC, Turneer M, Mercenier A. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect. Immun. 69, 1547-1553 (2001).
23. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharm. Des. 9, 175-191 (2003).
24. Pavan S, Desreumaux P, Mercenier A. Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clin. Diagn. Lab. Immunol. 10, 696-701 (2003).
25. Repa A, Grangette C, Daniel C et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 22, 87-95 (2003).
26. Cross ML, Gill HS. Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies? Int. Arch. Allergy Immunol. 125, 112-119 (2001).
27. Cross ML, Stevenson LM, Gill HS. Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria? Int. Immunopharmacol. 1, 891-901 (2001).
28. Maassen CB, Boersma WJ, van Holten-Neelen C, Claassen E, Laman JD. Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development. Vaccine 21, 2751-2757 (2003).
29. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107, 129-134 (2001).
30. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079 (2001).
31. Pochard P, Gosset P, Grangette C et al. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J. Allergy Clin. Immunol. 110, 617-623 (2002).
32. Grangette C, Nutten S, Palumbo E et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. USA 102, 10321-10326 (2005).
33. Okamoto N, Tezuka K, Kato M, Abe R, Tsuji T. PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production. Biochem. Biophys. Res. Commun. 310, 691-702 (2003).
34. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 9, 575-585 (1998).
35. Dillon S, Agrawal S, Banerjee K et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116, 916-928 (2006).
36. -/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176, 5788-5796 (2006).
37. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168, 171-178 (2002).
38. Janeway CA Jr. A trip through my life with an immunological theme. Annu. Rev. Immunol. 20, 1-28 (2002).
39. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
40. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298-300 (2002).
41. Kawai T, Akira S. TLR signaling. Semin. Immunol. 19, 24-32 (2007).
42. Akira S. TLR signaling. Curr. Top. Microbiol. Immunol. 311, 1-16 (2006.)
43. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
44. Thoma-Uszynski S, Kiertscher SM, Ochoa MT et al. Activation of Toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J. Immunol. 165, 3804-3810 (2000).
45. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163, 1-5 (1999).
46. Hoebe K, Du X, Georgel P et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743-748 (2003).
47. Hoebe K, Janssen EM, Kim SO et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4, 1223-1229 (2003).
48. Mohamadzadeh M, Duong T, Hoover T, Klaenhammer TR. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev. Vaccines 7(2), 163-174 (2008).
49. Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol. 6, 349-362 (2008).